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osting by EAbstract Background: Stimulation of the Na+–H+ exchanger during resuscitation following
hemorrhagic shock results in myocardial injury and dysfunction. Inhibition of the Na+–H+
exchanger appears to be a new pharmacological tool for myocardial protection following ische-
mia–reperfusion. Our lab showed that inhibition of the Na+–H+ exchanger, using amiloride and
dimethyl amiloride, before ex vivo resuscitation of isolated perfused hearts protected the myocar-
dium and improved the post-resuscitation myocardial function. The purpose of the present study
was to examine the myocardial protective effects of treating the hemorrhagic shocked rats by
intra-arterial injection of 20 lM dimethyl amiloride (DMA), a speciﬁc Na+–H+ exchanger blocker,
before in vivo resuscitation.
Methods: Sprague–Dawley rats were assigned to hemorrhagic treated or untreated groups (n= 4
per group). After 60 min of hemorrhagic shock, rats were treated or not by injection of 20 lM 5-
(N,N-dimethyl)-amiloride (DMA) intra-arterially. Rats were then resuscitated in vivo and moni-
tored for 30 min. Then hearts were harvested and perfused in the Langendorff system for 60 min
for measurements of hemodynamic function.
Results: Administration of DMA before in vivo resuscitation following 60 min of hemorrhagic
shock and 30 min of in vivo resuscitation, 20 lM DMA intra-arterially signiﬁcantly improved
post-resuscitation myocardial function.
Conclusion: Our results suggest that DMA protects the heart against post-resuscitation myocardial
injury.
ª 2009 King Saud University. All rights reserved.6725672.
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lsevier1. Introduction
Myocardial dysfunction and failure are among the major
causes of mortality following hemorrhagic shock (Gutierrez
et al., 2004). Activation of the Na+–H+ exchanger at the time
of resuscitation is a major component of the hemorrhagic
shock associatedmyocardial dysfunction and injury (Lazdunski
et al., 1985). The Na+–H+ exchanger is activated at reperfu-
sion due to the intracellular acidosis caused by anaerobic
160 M. Solimanmetabolism. The exchange of intracellular H+ for extracellular
Na+ causes Na+overload and subsequent activation of the
Na+–Ca2+exchanger that leads to an increase in intracellular
Ca2+, with its deleterious effects on myocardial contractility.
This has been supported by data from different research
groups in case of ischemia-reperfusion (Eng et al., 1998; Meng
et al., 1993; Pierce et al., 1993; Meng and Pierce, 1991; Meng
and Pierce, 1990). Thus, inhibition of Na+–H+ exchanger,
which would lead to prevention of Ca2+ overload, is a prom-
ising therapeutic approach against myocardial ischemia and
reperfusion injury (Piper et al., 1996; Frohlich and Karmazyn,
1997). However, the myocardial protective effects of blocking
the Na+–H+ exchanger before resuscitation following hemor-
rhagic shock is unclear.
Our laboratory studied the effects of blocking the Na+–H+
exchanger using amiloride before ex vivo as well as in vivo
resuscitation of hemorrhagic shocked rats. The results were
very promising showing improved myocardial contractility in
the treated animals. Previous work from our lab also showed
myocardial protective effects of blocking the Na+–H+ ex-
changer using 20 lM dimethyl amiloride (DMA), a speciﬁc
Na+–H+ exchanger blocker, before ex vivo resuscitation of
isolated hearts from hemorrhagic shock model. The objective
of this study was to determine the myocardial protective effects
of treating the hemorrhagic shock rats using DMA i.e. before
in vivo resuscitation of rats.2. Materials and methods
This study was approved by the Continuous Medical Research
Center at the College of Medicine, King Saud University. Six-
teen male Sprague–Dawley rats were used.2.1. Surgical procedure
Male Sprague-Dawley rats were injected intra-peritonealy
(i.p.) with heparin sodium 2000 I.U. 15 min prior to anesthe-
sia. The rats were then anaesthetized used urethane 125 mg/
kg intra-peritonealy. The left carotid artery was cannulated
using polyethylene tubing size 60, and was connected to an
in-line pressure transducer for continuous blood pressure mon-
itoring. Animals were allowed to stabilize for a period of
30 min. Animals were assigned randomly to either hemor-
rhagic shock or time matched control group (n= 4 per group).2.2. Hemorrhage and resuscitation
After 15 min stabilization, rats were hemorrhaged using a res-
ervoir (a 10 ml syringe). Blood was withdrawn from the caro-
tid artery until MAP reached 35–40 mmHg. Where in vivo
resuscitation was required, shed blood was reinfused to achieve
normotension (80–110 mmHg). If the blood pressure drops be-
low 30 mmHg or failed to be restored to normal, experiments
were excluded. The same surgical procedures were performed
for the sham hemorrhage groups except that rats were not
hemorrhaged.2.3. Experimental groups
1. Hemorrhagic shock group (HS)
2. DMA treated hemorrhagic shock group (DMA-HS)3. Sham hemorrhage group (Sham)
4. DMA treated sham hemorrhage group (DMA-Sham)2.4. Experimental design
Rats were randomly assigned to either: (1) hemorrhagic shock
of 60 min followed by in vivo resuscitation by reinfusion of
the shed blood to restore normotension, (2) DMA treated hem-
orrhagic shock group where animals hemorrhaged for 60 min
followed by treatment by injecting 1 ml of (20 lM) DMA dis-
solved in KHB intra-arterially, and resuscitation for 30 min,
(3) sham hemorrhage group where rats underwent same surgical
procedure and blood pressure monitored for 90 min and (4)
DMA treated sham hemorrhage group where rats underwent
same surgical procedure and blood pressure monitored for
60 min, then rats where treated by injecting 1 ml of (20 lM)
DMA dissolved in KHB intra-arterially, and monitored for
another 30 min.
2.5. Isolated heart perfusion
Hearts were excised quickly and rapidly placed onto a Lange-
ndorff system for perfusion in retrograde mode via the aorta;
at a rate of 10 mL/min. Hearts were perfused with KHB of the
following composition (in mM): sodium chloride, 118; calcium
chloride, 1.25; potassium chloride, 4.7; sodium bicarbonate,
21; magnesium sulphate, 1.2; glucose, 11; potassium biphos-
phate, 1.2; and EDTA, 0.5. An apical stab incision was made
in the left ventricle (LV) using a #15 scalpel blade. A saline-ﬁlled
cellophane balloon-tipped catheter was placed into the LV via
the mitral valve and was used to measure LV pressure and bal-
loon volume. LV and perfusion pressures were measured using
transducers placed at the levels of the heart and aorta. Hearts
were stimulated electrically at 5 Hz using electrical stimulator
(6020 Stimulator fromHarvard Apparatus). Perfusion pressure
was maintained at 50 mmHg. LVEDP was maintained at
5 mmHg. Perfusate temperature was maintained at 37 C. The
perfusate was gassed with a mixture of 95% O2 + 5% CO2 at
a pH of 7.4 for the duration of the experiment.
2.6. Hemodynamic and cardio dynamic measurements
Left ventricular end diastolic pressure (LVEDP) and the left
ventricular peak systolic pressure (LVPSP) were measured
continuously. Left ventricular max ±dP/dt were calculated.
2.7. Statistical analysis
Data were initially analyzed with Bartlett’s test for homogene-
ity. Data found not to be homogeneous were transformed and
reanalyzed. Data are presented as means and standard devia-
tions or standard errors. Data were analyzed with multivariate
analysis of variance (ANOVA). Means were analyzed using
Duncan’s test. Data were considered signiﬁcant when yielding
a p-value less than 0.05.3. Results
The myocardial contractile function was measured in the iso-
lated hearts after treatment and resuscitation of the animals.
Exposure to hemorrhagic shock resulted in myocardial
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Figure 1 Left ventricular end-diastolic pressure of the sham-
hemorrhage treated and untreated, hemorrhage treated and
untreated group over 1 h of ex vivo perfusion (n= 4).
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Figure 2 Left ventricular peak systolic pressure of the sham-
hemorrhage treated and untreated, hemorrhage treated and
untreated group over 1 h ex vivo perfusion (n= 4).
a = p< 0.05 compared to hemorrhage + DMA; b = p< 0.05
compared to sham hemorrhage; c = p< 0.05 compared to sham
hemorrhage + DMA.
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Figure 3 Left ventricular generated pressure of the sham-
hemorrhage treated and untreated, hemorrhage treated and
untreated group over 1 h ex vivo perfusion (n= 4).
a = p< 0.05 compared to hemorrhage + DMA; b = p< 0.05
compared to sham hemorrhage; c = p< 0.05 compared to sham
hemorrhage + DMA.
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Figure 4 Left ventricular +dP/dt of the sham-hemorrhage
treated and untreated, hemorrhage treated and untreated group
over 1 h ex vivo perfusion (n= 4).
Inhibition of Na+–H+ exchange before resuscitation following hemorrhagic shock 161contractile dysfunction as compared to controls. Treatment
with the Na+–H+ exchange blocker improved the myocardial
contractile function. LVEDP was elevated in the hemorrhage
group compared to the sham hemorrhage group (Fig. 1). Left
ventricular peak systolic pressure was signiﬁcantly higher in
the hemorrhage treated group as compared to the untreated
hemorrhage group (p< 0.05) (Fig. 2). Left ventricular gener-
ated pressure was signiﬁcantly low in the hemorrhage group
compared to the sham hemorrhage group and the hemorrhage
treated (Fig. 3). Left ventricular maximum+ dP/dt (Fig. 4)
was lower in the hemorrhage group as compared to the sham
hemorrhage group and the hemorrhage treated. Maximum
dP/dt was signiﬁcantly higher in the hemorrhage group than
the sham hemorrhage and the hemorrhage treated group
(p< 0.05) (Fig. 5), while dP/dt was signiﬁcantly lower in
the hemorrhage treated compared to the hemorrhage group(p< 0.05). In the hemorrhagic shock group, there was a signif-
icant drop in blood pressure as compared to controls (Fig. 6).
There was no signiﬁcant drop in blood pressure in the sham
hemorrhage treated as compared to the sham untreated group
(Fig. 6).
4. Discussion
The potential for successful resuscitation from traumatic hem-
orrhagic shock remains a challenge for management of trauma
patients. Hemorrhagic shock involves a complex interaction of
many pathophysiological pathways, metabolic acidosis, release
of ischemic metabolites and the stimulation of a cascade of
inﬂammatory process (Wu et al., 2008). The Na+–H+ exchan-
ger has been known to participate in the ischemia-reperfusion
injury and myocardial dysfunction by activating a series of
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Figure 5 Left ventricular dP/dt of the sham-hemorrhage
treated and untreated, hemorrhage treated and untreated group
over 1 h ex vivo perfusion (n= 4). a = p< 0.05 compared to
hemorrhage + DMA; b = p< 0.05 compared to sham hemor-
rhage; c = p< 0.05 compared to sham hemorrhage + DMA.
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Figure 6 Effects of adenosine on MAP at 90 min after resusci-
tation of 1 h of hemorrhagic shock. Data are means ± SE (n= 4).
*p< 0.05 as compared to the sham hemorrhage group.
162 M. Solimanevents that leads to cellular dysfunction and failure (Pierce and
Czubryt, 1995). Hemorrhagic shock results in the stimulation
of the Na+–H+ exchanger due to the metabolic acidosis. This
will cause Na+ overload which will eventually cause subse-
quent activation of the Na+Ca2+ exchanger and an increase
in the intracellular Ca2+, with its deleterious effects on myo-
cardial contractility (Eng et al., 1998; Meng et al., 1993; Pierce
et al., 1993; Meng and Pierce, 1990, 1991). Inhibition of the
Na+–H+ exchanger will prevent the rapid wash out of the
intracellular H+ by the Na+–H+ exchanger, and will allow
the cell to recover from acidosis by other pathways. This is
for a short period, then the exchanger will be stimulated grad-
ually. In this way, the Ca2+ overload is prevented and its con-
sequences on myocardial contractile function and structure
would be prevented.
Inhibition of theNa+–H+exchanger has been shown to pro-
tect the cells and preserve myocardial function in ischemia-
reperfusion injury (Kaba et al., 2008). However, there is lack
of information on the role of the Na+–H+ exchange inhibitors
in protecting the myocardial structure and function following
resuscitation of hemorrhagic shock. Our laboratory has previ-
ously shown that blocking the Na+–H+ exchanger usingdimethyl amiloride for short time before ex vivo resuscitation
of the isolated hearts in the Langendorff system, protected the
myocardium against post-resuscitation contractile dysfunction
(Soliman, in press). In the present studywe investigated themyo-
cardial protective effects of blocking the Na+–H+ exchanger
using DMA, a speciﬁc inhibitor, by treating the animals before
in vivo resuscitation following 1 h of hemorrhagic shock.
The present study showed that blocking the exchanger for a
short period of time before resuscitation improved the myocar-
dial contractile function with comparison to the non-treated
hemorrhagic shock group and prevent the post-resuscitation
dysfunction.
In summary our results demonstrate that inhibition of the ex-
changer before resuscitation of hemorrhagic shock has a strong
cardioprotective effect. Our result, therefore, suggests that the
exchanger is active during hemorrhagic shock and this activity
is an important contributory factor in myocardial dysfunction
and injury. This work strengthens the previous data that showed
the cardioprotective effects of blocking the exchanger in an iso-
lated resuscitated heart model (Soliman, in press) and opens a
new window for therapeutic strategies for the treatment of trau-
ma patients to prevent ischemia–reperfusion injury.Acknowledgements
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